Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
Objectives While important progress was made regarding the treatment of systemic sclerosis (SSc), there is still no evidence-based disease-modifying treatment available for SSc-related gastrointestinal (GI) manifestations. We aimed to identify an association between immunosuppressive therapy and the...
Saved in:
Main Authors: | Oliver Distler, Cosimo Bruni, Suzana Jordan, Carina Mihai, Muriel Elhai, Rucsandra Dobrota, Alexandru Garaiman, Mike Oliver Becker, Lea Stamm, Sherif Ismail, Norina Zampatti, Aurora Maria Tatu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/10/3/e004333.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation project
by: Maarten de Wit, et al.
Published: (2025-02-01) -
Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01) -
Immunosuppression and the Immune Response to Transplantation
by: David Ludwin, et al.
Published: (1993-01-01) -
Non-Anatomic Reconstruction in Multiligament Knee Injuries: A Functional Approach
by: Mihai Hurmuz, et al.
Published: (2025-01-01) -
Immunosuppressant-Associated Neurotoxicity Responding to Olanzapine
by: James A. Bourgeois, et al.
Published: (2014-01-01)